|6.16||-0.08 / -1.28%|
As of 3:59pm ET
|6.15||-0.01 / -0.16%|
The 1 analysts offering 12-month price forecasts for Northwest Biotherapeutics Inc have a median target of 15.10, with a high estimate of 15.10 and a low estimate of 15.10. The median estimate represents a +145.13% increase from the last price of 6.16.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.